You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Lung cancer

EGFR‑TK mutation testing in adults with locally advanced or metastatic non-small-cell lung cancer

  • Diagnostics guidance
  • Reference number: DG9
  • Published:  14 August 2013
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History
Download guidance (PDF)
  • Overview
  • 1 Recommendations
  • 2 The technologies
  • 3 Clinical need and practice
  • 4 The diagnostic tests
  • 5 Outcomes
  • 6 Considerations
  • 7 Recommendations for further research
  • 8 Implementation
  • 9 Related NICE guidance
  • 10 Review
  • 11 Diagnostics Advisory Committee members and NICE project team
  • 12 Sources of evidence considered by the Committee
  • About this guidance

10 Review

NICE will update the literature search at least every 3 years to ensure that relevant new evidence is identified. NICE will contact product sponsors and other stakeholders about issues that may affect the value of the diagnostic technology. NICE may review and update the guidance at any time if significant new evidence becomes available.

Andrew Dillon
Chief Executive
August 2013


Next page 11 Diagnostics Advisory Committee members and NICE project team Previous page 9 Related NICE guidance